JP Morgan Maintains Neutral on Xylem, Lowers Price Target to $118
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Mark Strouse maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $137 to $118.
JP Morgan analyst Mark Strouse maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $137 to $118.